Follow-The-Filings

Security · featured owners

ANAB Anaptysbio Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 7.5%
  • $52M
  • 1 new 1 reduce

ANAB (Anaptysbio Inc.) is held in 2 featured 13F books as of 2026 Q2. Scott Miller - Greenhaven Road Investment Man... is the largest tracked holder by portfolio weight (7.5%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 7.5% (Scott Miller - Greenhaven Road Investment Management) · not free-float ownership

  1. Scott Miller new 7.5%
  2. Palo Alto Investors reduce 5.6%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 5.6% Reduce −5.4% 603,489 $41M history
Scott Miller - Greenhaven Road Investment Management 2026 Q2 7.5% New 7.5% 171,059 $12M history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07,9.01 Filing Doc
8-K 7.01 Filing Doc
DEFA14A Filing Doc
8-K 1.01 Filing Doc
8-K 7.01 Filing Doc
8-K 5.03 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
10-K/A Filing Doc
8-K/A 9.01 Filing Doc
8-K 1.01,2.01,5.02,8.01,9.01 Filing Doc
8-K 1.01,1.02,5.02,7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Mar 12, 2026 · 2 forms Filing Doc
4 Period Jun 15, 2026 · 3 forms Filing Doc
4 Period May 11, 2026 · 2 forms Filing Doc
4 Period Apr 27, 2026 Filing Doc
4/A Period Apr 20, 2026 Filing Doc
4 Period Apr 20, 2026 · 5 forms Filing Doc
4 Period Mar 30, 2026 Filing Doc
4 Period Mar 25, 2026 Filing Doc
4 Period Feb 11, 2026 Filing Doc
4 Period Jan 15, 2026 Filing Doc
4 Period Jan 7, 2026 · 4 forms Filing Doc

Updated 26 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $17.16M $91.28M $234.6M
Net income -$163.62M -$145.23M -$13.23M
Net margin * -953.7% -159.1% -5.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $406.84M $431.88M $350.25M
Total non-current assets * $45.55M $51.96M $14.14M
Total assets $452.39M $483.83M $364.4M
Total current liabilities $37.44M $45.43M $38.62M
Total equity $88.1M $70.87M $37.21M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$120.8M -$135.34M $19.7M
Cash from investing $144.75M $95.4M $228.03M
Cash from financing -$59.3M $127.05M -$132.61M
Net change in cash -$35.34M $87.12M $115.12M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders